Press release
Pharmacy Compounding for Veterinary Medicine Market Forecast to Reach USD 2.35 Billion by 2030
Download the full report now to discover market trends, opportunities, and strategies for success.
https://evolvebi.com/report/pharmacy-compounding-for-veterinary-medicine-market-analysis/
The Role of Anti-inflammatory Agents
Anti-inflammatory agents, such as nonsteroidal anti-inflammatory drugs (NSAIDs) and corticosteroids, are crucial in veterinary medicine for managing pain and inflammation caused by conditions like osteoarthritis, injuries, and post-surgical recovery. While FDA-approved drugs exist, they are often not available in the necessary dosage forms, concentrations, or flavors for all animal species. This is where compounding plays a vital role. Pharmacists can create customized medications, such as flavored oral suspensions, transdermal gels, or smaller-dose capsules, that make it easier for pet owners to administer and ensure the animal receives the correct treatment. This enhanced patient compliance is a key driver for the demand for compounded anti-inflammatory agents.
Problems Faced
Despite the opportunities, the veterinary compounding market faces several challenges.
• Regulatory Scrutiny: Compounded medications are not subject to the same FDA approval process as commercially available drugs, raising concerns about their safety, efficacy, and potency. Studies have shown a wide variation in the effectiveness of compounded medications, with some products not containing the amount of active ingredient indicated on the label. This regulatory ambiguity and lack of consistent oversight can lead to serious adverse events.
• Cost and Sourcing: The lack of standardized formulas and the need for specific, high-quality ingredients can increase production costs. Additionally, the competition from large pharmaceutical companies with heavy R&D and marketing budgets poses a threat to smaller compounding pharmacies.
• Supply Chain Disruptions: Compounding relies on a consistent supply of Active Pharmaceutical Ingredients (APIs) and other raw materials, many of which are sourced internationally.
Download the full report now to discover market trends, opportunities, and strategies for success.
https://evolvebi.com/report/pharmacy-compounding-for-veterinary-medicine-market-analysis/
Proposed Solutions
To address these challenges, several solutions can be implemented to ensure the safety and growth of the market.
• Enhanced Quality Control: Compounding pharmacies can invest in advanced technology and stricter quality assurance protocols to ensure the potency, purity, and stability of their products. This includes mandatory third-party testing and adherence to established compounding standards.
• Veterinarian-Pharmacist Collaboration: Fostering a stronger partnership between veterinarians and compounding pharmacists can ensure that compounded medications are used only when medically necessary and that veterinarians are fully informed about the compounded product's formulation and administration.
• Consumer Education: Increased awareness campaigns for both pet owners and veterinarians can highlight the importance of using FDA-approved drugs whenever possible and the specific circumstances where a compounded medication is the best or only option.
US Tariff Implications
The US tariff policies have a notable impact on the veterinary compounding market. While finished pharmaceutical products are often exempt, tariffs can be levied on imported medical supplies and, most significantly, on the chemical precursors and APIs used in compounding. These tariffs, which can be as high as 25%, increase the cost of raw materials. This additional cost is often passed down the supply chain to distributors, veterinarians, and ultimately, the pet owner. This can lead to increased costs for treatments and, in some cases, potential drug shortages if foreign manufacturers abandon the production of low-margin generic ingredients.
Download the full report now to discover market trends, opportunities, and strategies for success.
https://evolvebi.com/report/pharmacy-compounding-for-veterinary-medicine-market-analysis/
To understand further and explore opportunities in the Pharmacy Compounding for Veterinary Medicine Market or any related industry please share your queries/concern at info@evolvebi.com.
Evolve Business Intelligence
C-218, 2nd floor, M-Cube
Gujarat 396191
India
Email: sales@evolvebi.com
Website: https://evolvebi.com/
Evolve Business Intelligence is a market research, business intelligence, and advisory firm providing
innovative solutions to challenging pain points of a business. Our market research reports include data
useful to micro, small, medium, and large-scale enterprises. We provide solutions ranging from mere
data collection to business advisory.
Evolve Business Intelligence is built on account of technology advancement providing highly accurate
data through our in-house AI-modelled data analysis and forecast tool - EvolveBI. This tool tracks real-
time data including, quarter performance, annual performance, and recent developments from
fortune's global 2000 companies.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pharmacy Compounding for Veterinary Medicine Market Forecast to Reach USD 2.35 Billion by 2030 here
News-ID: 4374199 • Views: …
More Releases from Evolve Business Intelligence
Plant-Based Meat Market Forecast to Reach USD 26.98 Billion by 2033
The plant-based meat market is at a pivotal point, marked by strong growth in the past decade but now facing headwinds. While traditional retail channels have seen recent slowdowns, the non-store-based segment, which includes direct-to-consumer (D2C) e-commerce, meal kits, and food service, presents a significant and largely untapped opportunity. This channel allows brands to bypass the challenges of traditional retail, such as intense competition for shelf space and high listing…
Nuclear Power Plant Market Forecast to Reach USD 40.75 Billion by 2033
As the world seeks a clean, reliable, and sustainable energy future, High Temperature Gas-Cooled Reactors (HTGRs) are emerging as a prime candidate to lead the next generation of nuclear power. This advanced reactor technology, which uses a graphite-moderated core and inert helium coolant, offers a unique blend of inherent safety and versatility that extends well beyond traditional electricity generation. While challenges remain, the opportunity for HTGRs to transform the nuclear…
LED Lighting Market Forecast to Reach USD 255.92 Billion by 2035
The global LED lighting market is on a trajectory of significant expansion, fueled by the rising demand for energy-efficient and sustainable lighting solutions. While the market for LED lamps remains strong, luminaires-complete lighting fixtures with integrated LEDs-are emerging as the primary driver of future growth. Valued at an estimated USD 71.59 billion in 2023, the market is projected to surge to over USD 255.92 billion by 2035, with a compound…
Sensor Market Forecast to Reach USD 457.26 Billion by 2032
The global sensor market is at a pivotal point, poised for remarkable growth driven by the proliferation of smart devices, industrial automation, and the Internet of Things (IoT). The market, valued at an estimated USD 241.06 billion in 2024, is projected to expand significantly to approximately USD 457.26 billion by 2032, demonstrating a robust Compound Annual Growth Rate (CAGR) of about 8.5%. Within this dynamic landscape, a key player is…
More Releases for Compounding
Compounding Pharmacies Business Development Strategies for Expanding Your Market …
The global compounding pharmacies market size was US$ 8.1 billion in 2021. The global compounding pharmacies market size is estimated to reach US$ 13.9 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.2% during the forecast period from 2022 to 2030.
Request To Download Sample of This Strategic Report :-https://reportocean.com/industry-verticals/sample-request?report_id=bwcc17220
A compounding pharmacy is a distinctive kind of pharmacy. They can create customized medicines for the individual who…
NBR Compounding Market Report Status And Outlook 2022-2027-Hexpol Compounding, P …
The NBR Compounding Market report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. We analyzed the impact of…
Global Compounding Pharmacies Market, Global Compounding Pharmacies Industry, Co …
The Compounding Pharmacies market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The Global Compounding Pharmacies Market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Compounding Pharmacies market. The report focuses on well-known providers in the global…
U.S. Compounding Pharmacies Market Global Key Players - Premier Pharmacy Labs, R …
Endowed with numerous regulatory compliances, the U.S. compounding pharmacies market has been traversing toward becoming one of the most profitable business spaces. Owing to the lack of safety and absence of clinical clearances, compounded medications have been under stringent scrutiny that has been helping players in the U.S. compounding pharmacies to strengthen their existing manufacturing practices. The surging use of compounded medicines for pain relief and hormone replacement therapies is…
U.S. Compounding Pharmacies Market ; Eminent Players - Pencol Compounding Pharma …
Endowed with numerous regulatory compliances, the U.S. compounding pharmacies market has been traversing toward becoming one of the most profitable business spaces. Owing to the lack of safety and absence of clinical clearances, compounded medications have been under stringent scrutiny that has been helping players in the U.S. compounding pharmacies to strengthen their existing manufacturing practices. The surging use of compounded medicines for pain relief and hormone replacement therapies is…
U.S. Compounding Pharmacies Market Key Players – McKesson Corporation, Nephron …
U.S. Compounding Pharmacies Market size is set to exceed USD 7 billion by 2025; according to a new research report by Global Market Insights, Inc.
Growing prevalence of chronic diseases in the U.S. such as cancer, diabetes, cardiovascular disease, respiratory diseases and obesity will drive the U.S. compounding pharmacies market growth over the forecast period. Increasing drug shortage in the country due to production delays and unavailability of previously manufactured…
